St Jude Medical wins CE Mark for EnSite Velocity cardiac mapping system

Published: 14-May-2009

To help physicians efficiently diagnose and deliver therapy to treat abnormal heart rhythms

St Jude Medical, a medical device company, has announced the European CE Mark approval and first use of its EnSite Velocity cardiac mapping system. The EnSite Velocity System is used in minimally invasive electrophysiology procedures.

According to St Jude Medical, the EnSite Velocity cardiac mapping system has been designed to help physicians more efficiently diagnose and deliver therapy to treat abnormal heart rhythms.

Advancements in the EnSite Velocity System's design are focused on increasing procedural efficiency, from set-up and operation, to clinical application and use. With new hardware and software, the system offers simple set-up and connections, an intuitive software interface and includes two key new capabilities: the OneMap tool and RealReview function.

The EnSite Velocity system continues its longstanding ability to visualize multiple catheters and electrodes and is the only mapping system capable of supporting both contact and non-contact mapping, giving the EnSite Velocity system unmatched versatility in its ability to map any arrhythmia, the company said.

Additionally, the EnSite Velocity system is an open platform, which means that it is compatible with essentially all diagnostic and ablation catheters, recording systems and energy sources used for ablation procedures, the company added.

Jane Song, president of atrial fibrillation division at St Jude Medical, said: The EnSite Velocity cardiac mapping system delivers the outstanding performance of the EnSite System, but with a new level of procedural efficiency. As the next generation in cardiac navigation and visualization technology, the EnSite Velocity system is designed to integrate seamlessly with existing lab technology, while having built-in flexibility to allow for integration with future technologies.